Watson Pharmaceuticals (WPI) receives WPI) receives final approval from the FDA for a generic...
Friday, October 26, 2012, 4:35 PM ETWatson Pharmaceuticals (WPI) receives final approval from the FDA for a generic version of Actos. began The company has already begun shipping the product. For the 12 months ending August 31, Actos and its generic equivalents had total U.S. sales of approximately $2.7B.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles